These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 22265361

  • 1. Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder.
    Olfson M, Huang C, Gerhard T, Winterstein AG, Crystal S, Allison PD, Marcus SC.
    J Am Acad Child Adolesc Psychiatry; 2012 Feb; 51(2):147-56. PubMed ID: 22265361
    [Abstract] [Full Text] [Related]

  • 2. Concomitant Use of Quinolones and Stimulants and the Risk of Adverse Cardiovascular Symptoms: A Retrospective Cohort Study.
    Alrwisan AA, Wei YJ, Brumback BA, Antonelli PJ, Winterstein AG.
    Pharmacotherapy; 2019 Dec; 39(12):1167-1178. PubMed ID: 31674031
    [Abstract] [Full Text] [Related]

  • 3. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A.
    Pediatrics; 2007 Dec; 120(6):e1494-501. PubMed ID: 18055666
    [Abstract] [Full Text] [Related]

  • 4. Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD.
    Winterstein AG, Gerhard T, Shuster J, Saidi A.
    Pediatrics; 2009 Jul; 124(1):e75-80. PubMed ID: 19564272
    [Abstract] [Full Text] [Related]

  • 5. Attention-deficit/hyperactivity disorder, stimulant therapy, and the patient with congenital heart disease: evidence and reason.
    Batra AS, Alexander ME, Silka MJ.
    Pediatr Cardiol; 2012 Mar; 33(3):394-401. PubMed ID: 22298228
    [Abstract] [Full Text] [Related]

  • 6. [Cardiovascular risks and management during Attention Deficit Hyperactivity Disorder treatment with methylphenidate].
    Bange F, Le Heuzey MF, Acquaviva E, Delorme R, Mouren MC.
    Arch Pediatr; 2014 Jan; 21(1):108-12. PubMed ID: 24309201
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder.
    Pliszka SR, Matthews TL, Braslow KJ, Watson MA.
    J Am Acad Child Adolesc Psychiatry; 2006 May; 45(5):520-526. PubMed ID: 16670648
    [Abstract] [Full Text] [Related]

  • 8. Managing stimulant medication for attention-deficit/hyperactivity disorder.
    Wender EH.
    Pediatr Rev; 2001 Jun; 22(6):183-90. PubMed ID: 11389305
    [No Abstract] [Full Text] [Related]

  • 9. Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review.
    Westover AN, Halm EA.
    BMC Cardiovasc Disord; 2012 Jun 09; 12():41. PubMed ID: 22682429
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study.
    Hennessy S, Schelleman H, Daniel GW, Bilker WB, Kimmel SE, Guevara J, Cziraky MJ, Strom BL.
    Pharmacoepidemiol Drug Saf; 2010 Sep 09; 19(9):934-41. PubMed ID: 20623519
    [Abstract] [Full Text] [Related]

  • 11. Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.
    Martinez-Raga J, Knecht C, Szerman N, Martinez MI.
    CNS Drugs; 2013 Jan 09; 27(1):15-30. PubMed ID: 23160939
    [Abstract] [Full Text] [Related]

  • 12. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B, Sopko MA, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.
    Ann Pharmacother; 2009 Jun 09; 43(6):1084-95. PubMed ID: 19470858
    [Abstract] [Full Text] [Related]

  • 13. [Medication for ADHD and the risk of cardiovascular mortality].
    Langendijk PN, Wilde AA.
    Ned Tijdschr Geneeskd; 2006 Aug 05; 150(31):1713-4. PubMed ID: 16924941
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular safety of stimulants in children with attention-deficit/hyperactivity disorder: a nationwide prospective cohort study.
    Dalsgaard S, Kvist AP, Leckman JF, Nielsen HS, Simonsen M.
    J Child Adolesc Psychopharmacol; 2014 Aug 05; 24(6):302-10. PubMed ID: 24956171
    [Abstract] [Full Text] [Related]

  • 15. Risks of Stimulant Use for Attention Deficit Hyperactivity Disorder on the Developing Brain: Primum non nocere.
    Stern HP, Lipman J, Andersen SL, Bossaer JB, Thigpen J.
    Clin Pediatr (Phila); 2017 Aug 05; 56(9):805-810. PubMed ID: 28459152
    [No Abstract] [Full Text] [Related]

  • 16. Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium.
    Huybrechts KF, Bröms G, Christensen LB, Einarsdóttir K, Engeland A, Furu K, Gissler M, Hernandez-Diaz S, Karlsson P, Karlstad Ø, Kieler H, Lahesmaa-Korpinen AM, Mogun H, Nørgaard M, Reutfors J, Sørensen HT, Zoega H, Bateman BT.
    JAMA Psychiatry; 2018 Feb 01; 75(2):167-175. PubMed ID: 29238795
    [Abstract] [Full Text] [Related]

  • 17. Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
    Moran LV, Ongur D, Hsu J, Castro VM, Perlis RH, Schneeweiss S.
    N Engl J Med; 2019 Mar 21; 380(12):1128-1138. PubMed ID: 30893533
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular safety of stimulant medications for pediatric attention-deficit hyperactivity disorder.
    Silva RR, Skimming JW, Muniz R.
    Clin Pediatr (Phila); 2010 Sep 21; 49(9):840-51. PubMed ID: 20693523
    [Abstract] [Full Text] [Related]

  • 19. Priapism associated with the use of stimulant medications and atomoxetine for attention-deficit/hyperactivity disorder in children.
    Eiland LS, Bell EA, Erramouspe J.
    Ann Pharmacother; 2014 Oct 21; 48(10):1350-5. PubMed ID: 24982313
    [Abstract] [Full Text] [Related]

  • 20. Motor skills of children newly diagnosed with Attention Deficit Hyperactivity Disorder prior to and following treatment with stimulant medication.
    Brossard-Racine M, Shevell M, Snider L, Bélanger SA, Majnemer A.
    Res Dev Disabil; 2012 Oct 21; 33(6):2080-7. PubMed ID: 22796639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.